Subscribe
Home
Issues
Online First
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
ESMO 2025 - Wrap-Up: Triple-Negative Breast Cancer
ASCO 2025 - Wrap-Up: Triple-Negative Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quiz
Press Releases
Association for Value-Based Cancer Care
Value-Based Care in Myeloma
Articles
Articles
The Number of Cancer Survivors on the Rise in the United States
Value Propositions
,
Value Peer-spectives
September 2012, Vol 3, No 6
Read More
Afinitor Gets the Nod for Metastatic Breast Cancer
FDA Approvals, News & Updates
September 2012, Vol 3, No 6
Read More
Carfilzomib Added to Multiple Myeloma Therapies
FDA Approvals, News & Updates
September 2012, Vol 3, No 6
Read More
Zaltrap Newest Drug for Metastatic Colorectal Cancer
FDA Approvals, News & Updates
September 2012, Vol 3, No 6
Read More
FDA Expedited Approval of Xtandi for Prostate Cancer
FDA Approvals, News & Updates
September 2012, Vol 3, No 6
Read More
Bosulif Approved for Ph+ CML
FDA Approvals, News & Updates
September 2012, Vol 3, No 6
Read More
Economics Impede Growth of Supportive Care Services
By
Phoebe Starr
Economics & Value
,
Economics of Cancer Care
,
MASCC Symposium
September 2012, Vol 3, No 6
New York, NY—Supportive care is effective in improving outcomes, but the growth of supportive care programs is hampered by economics, explained Eduardo Bruera, MD, Chair, Palliative Care & Rehabilitation Medicine, University of Texas M.D. Anderson Cancer Center, Houston, speaking at the 2012 Multinational Association of Supportive Care in Cancer International Symposium.
Read More
New Calculator Shows Financial Impact of Poor Quality of Care to an Institution, and How to Correct It
Head and Neck Cancer
,
Quality Care
,
Policies & Guidelines
September 2012, Vol 3, No 6
Read More
Living Life to the Fullest, with Cancer
Palliative Care
,
Personalized Medicine
September 2012, Vol 3, No 6
Amy J. Berman, BS, RN, was diagnosed with incurable stage IV breast cancer almost 2 years ago. In the following interview, she discusses with Value-Based Cancer Care (VBCC) her recent experience, and why she chose to focus on quality of life rather than on the length of her life.
Read More
Quality of Life Drives Patient Preference for Metastatic Renal-Cell Carcinoma Drug
By
Wayne Kuznar
ASCO Annual Meeting
,
ASCO
July 2012, Vol 3, No 5
Chicago, IL—The surprising results of a randomized trial on patient preference for one cancer therapy over another show that patient-reported quality-of-life (QOL) differences influence treatment preference far more than physicians had imagined, suggested researchers at the 2012 American Society of Clinical Oncology meeting.
Read More
Page 282 of 329
279
280
281
282
283
284
285
Top Trending Articles
1.
ACCC Federal Policy Update Highlights Key Risks and Opportunities for Oncology Practices in 2026
Meg Barbor, MPH
2.
From Chaos to Clarity: Data-Driven Denial Prevention
Shawntea (Taya) Gordon, MBA, FACMPE
3.
The Evolving Landscape of Lung Cancer Care
Meg Barbor, MPH
Home
Issues
Online First
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
ESMO 2025 - Wrap-Up: Triple-Negative Breast Cancer
ASCO 2025 - Wrap-Up: Triple-Negative Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quiz
Press Releases
Association for Value-Based Cancer Care
Value-Based Care in Myeloma